• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
JNS

JANUS ELECTRIC HOLDINGS LIMITED - News & Media

10.0% ! 13.5¢
Market Cap $13.48M  !
Utilities Utilities - Independent Power Producers
Add to My Watchlist

Janus Electric Holdings Ltd, formerly ReNu Energy Limited, is an Australia-based... Janus Electric Holdings Ltd, formerly ReNu Energy Limited, is an Australia-based cutting-edge electric vehicle technology company. The Company’s viable next generation battery technology delivers a zero-carbon solution for the electrification of road transport fleets. Janus Electric technology features a battery that can be charged utilizing renewable energy sources such as solar, wind and hydro. Its Janus (patent pending) Change & Charge Station utilizes renewable energy to provide a three-way system - grid to battery, battery to battery, and battery to grid. This enables renewable energy to be fed back into the grid, assisting balance and minimizing surges and outages. The Janus fleet electrification solution provides up to a 60% reduction in maintenance and operating costs over the vehicle's lifetime.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Articles & Videos

Janus Electric locks up 'priority' supply deal with Canadian lithium-ion battery designer

Janus Electric Holdings (ASX:JNS) has secured a commercial supply agreement that guarantees the supply of @next-generation” lithium-ion battery packs to support the company’s heavy transport electrification plans.Listen to the HotCopper podcast for in-depth d...

08 Jul 2025 10:04 (AEST)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
13.5¢ 		Change
-0.015(10.0%) 		Mkt cap ! $13.48M
Open High Low Value Volume
14.0¢ 14.0¢ 13.0¢ $17.27K 126.4K

Buyers (Bids)

No. Vol. Price($)
1 15 13.5¢
 

Sellers (Offers)

Price($) Vol. No.
14.5¢ 78206 3
View Market Depth
Last trade - 10.15am 31/07/2025 (20 minute delay) ?
Last
13.0¢ 		  Change
-0.015 ( 10.3 %)
Open High Low Volume
13.0¢ 13.0¢ 12.5¢ 9382
Last updated 10.46am 31/07/2025 ?
JNS (ASX) Chart

Top Stories

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Let’s check in with what HotCopper users are closely watching at lunchtime. Given that we’re basically on the deadline before companies get a scolding if they don’t report updates, on Wednesday, the ASX announcements list is basically one big wall o...
ASX Market Open: Local bourse tipped to trade red after same on S&P500 The local market is tipped to trade red on Thursday following the S@P500 declining -0.12% overnight (though, the NASDAQ ended 30pts higher.) This comes even after the ASX200 re-entered record territory on Wednesday following a CPI read widely perceived as a signal the RBA is likely to cut in Augu...
Ionic Rare Earths falls -7% as momentum slips on vague production update Ionic Rare Earths (ASX:IXR) @ a well-known and much-loved rare earths darling on something of a comeback run lately @ has slipped -7%, presumably as the market digests what a vague update released on Wednesday actually means. According to the company, @urgent supply requests from US, European and...
ASX Market Close: Index rebounds as investors buoyant | July 30, 2025 The ASX200 rebounded today and was in the green heading into the close. Investors were buoyant in response to positive inflation data that increased the odds of an interest rate cut in August.Staples, Real Estate and Discretionary were the strongest performing sectors. Utilities and IT were a dra...
Neurizon inks $1.5M loan against R&D Tax Rebate Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.